A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition to continue immunotherapy treatment for the first time.

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

Via Christi is the first hospital in the region to perform a new procedure for atrial fibrillation for patients who can’t ...

Shortly after putting out her dark electro new single “Disease,” Lady Gaga has shared its official music video. In the newly-released visuals, Gaga confronts different versions of herself ...

After more heart failure hospitalization in the past 6 months. Presence of all the above despite 'attempts to optimize' therapy, including diuretics, renin-angiotensin-aldosterone system and ß ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...

Failure is held up as a motivator ... In one study, participants predicted the likelihood that a heart attack survivor would make positive changes in their behavior. Without any additional ...

UCLA scientists have developed an antibody-based therapy that enhances heart repair after heart attacks, reducing scar tissue and heart failure risk by inhibiting ENPP1 protein. Preclinical trials are ...

Heart failure is an increasingly common and fatal disease and causes a heavy patient, health care–system, and cost burden. A cost-effectiveness study looking at different scenarios of achieving ...

Background: Standard pharmacotherapy for patients with heart failure with reduced ejection fraction (HFrEF) comprises “quadruple therapy” with a renin–angiotensin system inhibitor, a β-blocker, a ...

The medication has shown the ability to decrease cardiovascular-related deaths by 17%, while significantly reducing the need for hospitalization due to heart failure by 76%. Perhaps most striking ...